Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jan;99(1):21–26. doi: 10.1111/j.1476-5381.1990.tb14647.x

Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep.

S E Webber 1, R O Salonen 1, J G Widdicombe 1
PMCID: PMC1917526  PMID: 2331572

Abstract

1. The effects of 5-hydroxytryptamine (5-HT) and the selective 5-HT3 receptor agonist 2-methyl-5-HT were examined on the tracheal vasculature in anaesthetised, paralysed and artificially ventilated sheep. The cranial tracheal arteries were perfused with blood at constant flow and perfusion pressure was measured. 5-HT and 2-methyl-5-HT were injected into the arterial perfusate. Changes in tracheal smooth muscle tone were also measured. 2. 5-HT contracted the tracheal smooth muscle. This contraction was not affected by the 5-HT2 receptor antagonist ketanserin, but was blocked by the combined '5-HT1-like' and 5-HT2 receptor antagonist methysergide. 2-methyl-5-HT had no effect on the tracheal smooth muscle. 3. 5-HT had a complex action on the tracheal vasculature producing either a biphasic change (vasoconstriction followed by dilatation) or just a constriction. 2-methyl-5-HT had a weak vasoconstrictor effect. 4. The vasoconstrictions produced by 5-HT and 2-methyl-5-HT were blocked by ketanserin. The vasodilatation produced by 5-HT was resistant to ketanserin but was antagonised by methysergide. 5. Thus 5-HT contracts the tracheal smooth muscle of sheep by stimulating '5-HT1-like' receptors. 5-HT constricts the tracheal vascular bed by stimulating 5-HT2 receptors or dilates the vascular bed by stimulating '5-HT1-like' receptors. 5-HT3 receptors appear not to be involved in the responses of the tracheal vasculature or smooth muscle to 5-HT.

Full text

PDF
21

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baier H., Long W. M., Wanner A. Bronchial circulation in asthma. Respiration. 1985;48(3):199–205. doi: 10.1159/000194830. [DOI] [PubMed] [Google Scholar]
  2. Bayol A., Benveniste J., Brink C., Cerrina J., Gateau O., Labat C., Raffestin B. Response and sensitivity of guinea-pig airway muscle preparations to 5-hydroxytryptamine during ontogenesis. Br J Pharmacol. 1985 Jul;85(3):569–574. doi: 10.1111/j.1476-5381.1985.tb10550.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Connor H. E., Feniuk W. Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery. Br J Pharmacol. 1989 Jan;96(1):170–178. doi: 10.1111/j.1476-5381.1989.tb11797.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cushley M. J., Wee L. H., Holgate S. T. The effect of inhaled 5-hydroxytryptamine (5-HT, serotonin) on airway calibre in man. Br J Clin Pharmacol. 1986 Oct;22(4):487–490. doi: 10.1111/j.1365-2125.1986.tb02923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deffebach M. E., Charan N. B., Lakshminarayan S., Butler J. The bronchial circulation. Small, but a vital attribute of the lung. Am Rev Respir Dis. 1987 Feb;135(2):463–481. doi: 10.1164/arrd.1987.135.2.463. [DOI] [PubMed] [Google Scholar]
  6. Fozard J. R. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 1984 Dec;23(12B):1473–1486. doi: 10.1016/0028-3908(84)90091-1. [DOI] [PubMed] [Google Scholar]
  7. Frenken M., Kaumann A. J. Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jul;326(4):334–339. doi: 10.1007/BF00501438. [DOI] [PubMed] [Google Scholar]
  8. GADDUM J. H., PICARELLI Z. P. Two kinds of tryptamine receptor. Br J Pharmacol Chemother. 1957 Sep;12(3):323–328. doi: 10.1111/j.1476-5381.1957.tb00142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Laitinen L. A., Laitinen M. V., Widdicombe J. G. Parasympathetic nervous control of tracheal vascular resistance in the dog. J Physiol. 1987 Apr;385:135–146. doi: 10.1113/jphysiol.1987.sp016488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lemoine H., Kaumann A. J. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):91–97. doi: 10.1007/BF00506509. [DOI] [PubMed] [Google Scholar]
  11. Martin G. R., Leff P., Cambridge D., Barrett V. J. Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):365–373. doi: 10.1007/BF00164867. [DOI] [PubMed] [Google Scholar]
  12. Morley J., Sanjar S., Page C. P. The platelet in asthma. Lancet. 1984 Nov 17;2(8412):1142–1144. doi: 10.1016/s0140-6736(84)91567-8. [DOI] [PubMed] [Google Scholar]
  13. Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979 Nov;16(3):687–699. [PubMed] [Google Scholar]
  14. Raffestin B., Cerrina J., Boullet C., Labat C., Benveniste J., Brink C. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exp Ther. 1985 Apr;233(1):186–194. [PubMed] [Google Scholar]
  15. Sahin G., Webber S. E., Widdicombe J. G. Chemical control of tracheal vascular resistance in dogs. J Appl Physiol (1985) 1987 Sep;63(3):988–995. doi: 10.1152/jappl.1987.63.3.988. [DOI] [PubMed] [Google Scholar]
  16. Sahin G., Webber S. E., Widdicombe J. G. Lung and cardiac reflex actions on the tracheal vasculature in anaesthetized dogs. J Physiol. 1987 Jun;387:47–57. doi: 10.1113/jphysiol.1987.sp016561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Salonen R. O., Webber S. E., Widdicombe J. G. Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo. Br J Pharmacol. 1988 Dec;95(4):1262–1270. doi: 10.1111/j.1476-5381.1988.tb11763.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Selig W. M., Bloomquist M. A., Cohen M. L., Fleisch J. H. Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction. Pulm Pharmacol. 1988;1(2):93–99. doi: 10.1016/s0952-0600(88)80005-x. [DOI] [PubMed] [Google Scholar]
  19. Sheller J. R., Holtzman M. J., Skoogh B. E., Nadel J. A. Interaction of serotonin with vagal- and ACh-induced bronchoconstriction in canine lungs. J Appl Physiol Respir Environ Exerc Physiol. 1982 Apr;52(4):964–966. doi: 10.1152/jappl.1982.52.4.964. [DOI] [PubMed] [Google Scholar]
  20. Sinanović O., Chiba S. Pharmacological analysis of 5-HT-induced vasoconstriction in isolated, perfused dog skeletal muscle arteries. Eur J Pharmacol. 1987 Nov 17;143(3):353–360. doi: 10.1016/0014-2999(87)90459-6. [DOI] [PubMed] [Google Scholar]
  21. Sirek A., Sirek O. V. Serotonin: a review. Can Med Assoc J. 1970 Apr 25;102(8):846–849. [PMC free article] [PubMed] [Google Scholar]
  22. Stewart D. J., Holtz J., Pohl U., Bassenge E. Balance between endothelium-mediated dilating and direct constricting actions of serotonin on resistance vessels in the isolated rabbit heart. Eur J Pharmacol. 1987 Nov 3;143(1):131–134. doi: 10.1016/0014-2999(87)90743-6. [DOI] [PubMed] [Google Scholar]
  23. Webber S. E., Salonen R. O., Widdicombe J. G. H1- and H2-receptor characterization in the tracheal circulation of sheep. Br J Pharmacol. 1988 Oct;95(2):551–561. doi: 10.1111/j.1476-5381.1988.tb11676.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES